Tiziana Life Sciences (TLSA) Competitors $1.69 -0.10 (-5.59%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.67 -0.02 (-1.18%) As of 09/12/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLSA vs. DAWN, TNGX, IMTX, NRIX, OCS, NAGE, VALN, GYRE, GHRS, and VIRShould you be buying Tiziana Life Sciences stock or one of its competitors? The main competitors of Tiziana Life Sciences include Day One Biopharmaceuticals (DAWN), Tango Therapeutics (TNGX), Immatics (IMTX), Nurix Therapeutics (NRIX), Oculis (OCS), Niagen Bioscience (NAGE), Valneva (VALN), Gyre Therapeutics (GYRE), GH Research (GHRS), and Vir Biotechnology (VIR). These companies are all part of the "pharmaceutical products" industry. Tiziana Life Sciences vs. Its Competitors Day One Biopharmaceuticals Tango Therapeutics Immatics Nurix Therapeutics Oculis Niagen Bioscience Valneva Gyre Therapeutics GH Research Vir Biotechnology Day One Biopharmaceuticals (NASDAQ:DAWN) and Tiziana Life Sciences (NASDAQ:TLSA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk. Which has higher valuation & earnings, DAWN or TLSA? Tiziana Life Sciences has lower revenue, but higher earnings than Day One Biopharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDay One Biopharmaceuticals$131.16M5.56-$95.50M-$0.95-7.49Tiziana Life SciencesN/AN/A-$11.86MN/AN/A Do insiders and institutionals hold more shares of DAWN or TLSA? 88.0% of Day One Biopharmaceuticals shares are held by institutional investors. 6.2% of Day One Biopharmaceuticals shares are held by company insiders. Comparatively, 39.8% of Tiziana Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is DAWN or TLSA more profitable? Tiziana Life Sciences has a net margin of 0.00% compared to Day One Biopharmaceuticals' net margin of -50.63%. Tiziana Life Sciences' return on equity of 0.00% beat Day One Biopharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Day One Biopharmaceuticals-50.63% -19.01% -16.99% Tiziana Life Sciences N/A N/A N/A Which has more volatility & risk, DAWN or TLSA? Day One Biopharmaceuticals has a beta of -1.25, suggesting that its share price is 225% less volatile than the S&P 500. Comparatively, Tiziana Life Sciences has a beta of -0.36, suggesting that its share price is 136% less volatile than the S&P 500. Do analysts recommend DAWN or TLSA? Day One Biopharmaceuticals currently has a consensus target price of $25.29, suggesting a potential upside of 255.14%. Given Day One Biopharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe Day One Biopharmaceuticals is more favorable than Tiziana Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Day One Biopharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Tiziana Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer DAWN or TLSA? In the previous week, Day One Biopharmaceuticals and Day One Biopharmaceuticals both had 5 articles in the media. Day One Biopharmaceuticals' average media sentiment score of 1.36 beat Tiziana Life Sciences' score of 0.18 indicating that Day One Biopharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Day One Biopharmaceuticals 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Tiziana Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryDay One Biopharmaceuticals beats Tiziana Life Sciences on 7 of the 13 factors compared between the two stocks. Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSA vs. The Competition Export to ExcelMetricTiziana Life SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$209.16M$3.19B$5.85B$10.14BDividend YieldN/A2.30%5.68%4.60%P/E RatioN/A21.4375.3425.98Price / SalesN/A429.47514.55181.19Price / CashN/A46.6837.5660.44Price / Book42.259.6112.156.29Net Income-$11.86M-$53.29M$3.29B$271.07M7 Day Performance1.81%0.13%0.74%3.87%1 Month Performance-20.66%5.61%4.82%4.88%1 Year Performance82.72%10.49%60.58%26.12% Tiziana Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSATiziana Life Sciences0.5582 of 5 stars$1.69-5.6%N/A+82.1%$209.16MN/A0.008Short Interest ↑High Trading VolumeDAWNDay One Biopharmaceuticals3.0993 of 5 stars$7.47-1.1%$25.29+238.5%-47.9%$773.36M$131.16M-7.8660Positive NewsTNGXTango Therapeutics1.8269 of 5 stars$6.81-1.9%$10.50+54.2%-34.7%$772.15M$42.07M-5.1290News CoverageInsider TradeIMTXImmatics2.921 of 5 stars$5.81-7.2%$14.67+152.4%-53.3%$760.90M$168.65M-8.94260Positive NewsNRIXNurix Therapeutics2.3792 of 5 stars$9.70-2.1%$29.07+199.7%-61.6%$757.61M$54.55M-3.72300News CoveragePositive NewsOCSOculis3.1383 of 5 stars$17.25+0.2%$35.75+107.2%+45.6%$751.86MN/A-6.462Analyst UpgradeShort Interest ↓NAGENiagen Bioscience2.2433 of 5 stars$9.45+0.4%$13.42+42.0%N/A$750.47M$99.60M45.00120Positive NewsAnalyst DowngradeVALNValneva2.8015 of 5 stars$8.52-1.5%$15.00+76.1%+28.1%$743.27M$183.52M-8.69700Short Interest ↓Gap DownGYREGyre Therapeutics1.6848 of 5 stars$7.89+2.6%$18.00+128.1%-43.0%$740.65M$105.76M789.7940News CoveragePositive NewsAnalyst RevisionGHRSGH Research2.3931 of 5 stars$13.51-4.1%$32.00+136.9%+41.1%$733.08MN/A-18.2610VIRVir Biotechnology3.2567 of 5 stars$5.19-1.5%$26.80+416.4%-36.4%$732.09M$74.21M-1.30580 Related Companies and Tools Related Companies DAWN Competitors TNGX Competitors IMTX Competitors NRIX Competitors OCS Competitors NAGE Competitors VALN Competitors GYRE Competitors GHRS Competitors VIR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLSA) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tiziana Life Sciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Tiziana Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
